Page 9 - Pacific Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share: BioCardia (NASDAQ: BCDA) shares are trading higher. The company said it anticipates data safety monitoring board verbal feedback by the end of Dec. 15 for its pivotal Phase 3 CardiAMP Heart Failure Trial. BioCardia is a clinical stage regenerative medicine company. It is developing therapeutics for cardiovascular diseases with large unmet medical needs. BioCardia shares were trading up 78.37% at $5.03. The stock has a 52-week range between $6.75 and $1.91. Pacific Biosciences (NASDAQ: PACB) shares are trading higher after the company announced three of the United Kingdom's leading core...

Leading UK Core Labs Expand Investment in PacBio Sequencing Systems to Power Life Science Research with HiFi Reads Edinburgh Genomics, Oxford Genomics Centre, and University of Liverpool Centre for Genomic Research have added new PacBio Sequel II & IIe Systems to their service laboratories Pacific Biosciences of California, Inc. Menlo Park, California, UNITED STATES MENLO PARK, Calif., Dec. 14, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenome...